Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001288123-10-000030)

Filing Details

Accession Number:: 0001288123-10-000030
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2010-04-28 13:00:00
Reporting Period:: 2010-04-26

Filing Date:: 2010-04-28
Accepted Time:: 2010-04-28 14:14:49
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1098972	Antigenics Inc	AGEN	Biological Products, (No Disgnostic Substances) (2836)	061562417

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1377202	Shalini Sharp	C/O Antigenics Inc. 162 Fifth Ave., Suite 900 New York NY 10010	Cfo	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2010-04-26	3,750	$1.19	240,818	No	4	A	Direct
Common Stock	Disposition	2010-04-27	1,950	$1.16	238,868	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	A	Direct
No	4	S	Direct

Footnotes

Represents settlement of restricted stock awarded on January 26, 2010.
Represents only shares sold to cover minimum federal, state, and local tax withholding requirements upon the vesting of the restricted shares awarded on January 26, 2010. This sale was made through a Rule 10b5-1 trading plan.